UiPath (NYSE:PATH) Given New $27.00 Price Target at Evercore ISI

UiPath (NYSE:PATH) had its price objective lifted by Evercore ISI from $24.00 to $27.00 in a research report released on Thursday, Benzinga reports. The brokerage currently has an in-line rating on the healthcare company’s stock.

Several other analysts have also recently commented on the stock. Mizuho increased their price target on shares of UiPath from $18.00 to $22.00 and gave the company a neutral rating in a research note on Friday, December 1st. Scotiabank initiated coverage on shares of UiPath in a report on Wednesday, February 21st. They issued a sector perform rating on the stock. Morgan Stanley raised their target price on shares of UiPath from $17.00 to $25.00 and gave the company an equal weight rating in a research report on Thursday. Wells Fargo & Company raised their target price on shares of UiPath from $18.00 to $20.00 and gave the company an equal weight rating in a research report on Friday, December 1st. Finally, BMO Capital Markets lifted their target price on shares of UiPath from $19.00 to $24.00 and gave the stock a market perform rating in a report on Friday, December 1st. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, UiPath presently has an average rating of Hold and an average price target of $27.13.

UiPath Stock Performance

UiPath stock traded up $0.32 during trading hours on Thursday, hitting $23.07. 9,842,354 shares of the stock were exchanged, compared to its average volume of 10,074,664. UiPath has a 12 month low of $12.38 and a 12 month high of $27.87. The business’s 50-day moving average is $23.52 and its two-hundred day moving average is $20.70. The stock has a market capitalization of $13.06 billion, a P/E ratio of -135.46 and a beta of 0.97.

Insider Transactions at UiPath

In other news, CFO Ashim Gupta sold 70,000 shares of the stock in a transaction dated Monday, January 8th. The shares were sold at an average price of $23.02, for a total value of $1,611,400.00. Following the sale, the chief financial officer now directly owns 788,148 shares of the company’s stock, valued at $18,143,166.96. The sale was disclosed in a legal filing with the SEC, which is available at this link. In related news, Director Rich Wong sold 200,000 shares of the firm’s stock in a transaction that occurred on Monday, January 8th. The shares were sold at an average price of $23.12, for a total value of $4,624,000.00. Following the sale, the director now directly owns 429,418 shares of the company’s stock, valued at $9,928,144.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Ashim Gupta sold 70,000 shares of UiPath stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $23.02, for a total transaction of $1,611,400.00. Following the transaction, the chief financial officer now directly owns 788,148 shares in the company, valued at $18,143,166.96. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 411,000 shares of company stock valued at $9,418,670. 31.03% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its holdings in shares of UiPath by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 38,084,858 shares of the healthcare company’s stock worth $946,028,000 after purchasing an additional 334,085 shares during the last quarter. Gerber LLC bought a new position in shares of UiPath in the fourth quarter worth approximately $455,000. Sierra Summit Advisors LLC bought a new position in shares of UiPath in the fourth quarter worth approximately $5,897,000. GSA Capital Partners LLP bought a new position in shares of UiPath in the fourth quarter worth approximately $259,000. Finally, Public Employees Retirement System of Ohio grew its holdings in shares of UiPath by 4.1% in the fourth quarter. Public Employees Retirement System of Ohio now owns 159,357 shares of the healthcare company’s stock worth $3,958,000 after purchasing an additional 6,335 shares during the last quarter. 59.04% of the stock is owned by hedge funds and other institutional investors.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.